Medical Policy

D-1193-003

Policy Id

HHO-DE-MP-1193

Topic

Biofeedback

Section

Therapy Services

Effective Date

Jun 16, 2025

Issued Date

May 16, 2025

Last Revision Date

05/2025

Annual Review

06/2026

Prepared By

K. O'Toole

DISCLAIMER

Highmark medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions.

POLICY STATEMENT

This policy provides information regarding the coverage of, as determined by applicable federal and/or state legislation. 

This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records.

The qualifications of the policy will meet the standards of the National Committee for Quality Assurance (NCQA) and the Delaware Department of Health and Social Services (DHSS) and all applicable state and federal regulations. 

Policy Position

Prior Authorization

Prior Authorization may be required. Please validate codes on the Prior Authorization Lookup Tool https://www.highmarkhealthoptions.com/providers/prior-auth-lookup

Procedures

 

  Biofeedback for constipation in adults may be considered medically necessary for individuals with dyssynergia-type constipation as demonstrated by meeting ALL of the following criteria:

  • Symptoms of functional constipation that meet ROME IV criteria; and
  • Objective physiologic evidence of pelvic floor dyssynergia demonstrated by inappropriate contraction of the pelvic floor muscles or less than 20% relaxation of basal resting sphincter pressure by manometry, imaging, or electromyography (EMG); and
  • Failed a three (3) month trial of standard treatments for constipation including laxatives, dietary changes, and exercises (as many of the previous as are tolerated).

Biofeedback may be considered medically necessary as part of the overall treatment plan for migraine and tension-type headache. Before a biofeedback program is introduced, a physician must determine that the headaches are not pathological in nature. Such pathologies include:

  • Brain tumors; or
  • Hematoma; or
  • Edema; or
  • Aneurysm; or
  • Disease of the eyes, ears, or sinus.

Biofeedback may be considered medically necessary for the treatment of stress and/or urge incontinence in cognitively intact individuals who have failed a documented trial of pelvic muscle exercise (PME) training. A failed trial is defined as no clinically significant improvement in urinary continence after completing four (4) weeks of an ordered regimen of PMEs.

Biofeedback using capnometry guided respiratory intervention (CGRI) (e.g., Freespira) may be considered medically necessary as part of the overall treatment plan for adult individuals (age 18 and older) diagnosed with panic disorder and/or posttraumatic stress disorder (PTSD) when the individual can participate in the treatment plan (physically and cognitively).

Biofeedback, not meeting the criteria as indicated in this policy is considered experimental/investigational, and therefore noncovered because the safety and efficacy cannot be established by the review of the available published peer-reviewed literature.

    Functional constipation ROME IV diagnostic criteria

  • Must include two or more of the following:

            o   Straining during at least 25% of defecations; or

            o   Lumpy or hard stools in at least 25% of defecations; or

            o   Sensation of incomplete evacuation for at least 25% of defecations; or

            o   Sensation of anorectal obstruction/blockage for at least 25% of defecations; or

            o   Manual maneuvers to facilitate at least 25% of defecations (e.g., digital evacuation, support of the pelvic floor); or

            o   Fewer than three defecations per week; and

  • Loose stools are rarely present without the use of laxatives; and
  • Insufficient criteria for irritable bowel syndrome.

*Criteria fulfilled for the last three (3) months with symptom onset at least six (6) months prior to diagnosis.

    Post-payment audit statement

The medical record must include documentation that reflects the medical necessity criteria and is subject to audit by Highmark Health Options at any time pursuant to the terms of your provider agreement.

    Place of service: inpatient/outpatient

Experimental/investigational (E/I) services are not covered regardless of place of service.

Biofeedback is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a comorbid condition that would require monitoring in a more controlled environment such as the inpatient setting.

CPT code

Description

90875

Individual psychophysiological therapy incorporating biofeedback training by any modality (face to face with the patient), with psychotherapy (eg, insight oriented behavior modifying or supportive psychotherapy ) 30 minutes

90876

Individual psychophysiological therapy incorporating biofeedback training by any modality (face to face with the patient), with psychotherapy (eg, insight oriented behavior modifying or supportive psychotherapy ) 45 minutes

90901

Biofeedback training by any modality

90912

Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; initial 15 minutes of one-on-one physician or other qualified health care professional contact with the patient.

90913

Biofeedback training, perineal muscles, anorectal or urethral sphincter, including EMG and/or manometry, when performed; each additional 15 minutes of one-on-one physician or other qualified health care professional contact with the patient.

A9279

Monitoring feature/device, stand alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified

E0746

Electromyography (emg), Biofeedback device

Codes

 

 

 

 

 

 

F40.01

F41.0

G43.001

G43.009

G43.011

G43.019

G43.101

G43.109

G43.111

G43.119

G43.401

G43.409

G43.411

G43.419

G43.501

G43.509

G43.511

G43.519

G43.701

G43.709

G43.711

G43.719

G43.801

G43.809

G43.811

G43.819

G43.901

G43.909

G43.911

G43.919

G44.201

G44.209

G44.211

G44.219

G44.221

G44.229

K59.00

K59.01

K59.02

K59.03

K59.04

K59.09

N39.3

N39.41

N39.46

N39.491

N39.492

R15.0

R15.1

R15.2

R15.9

R32

 

 

 

 

Reimbursement

Participating facilities will be reimbursed per their Highmark Health Options contract. 

References

Kaplan A, Mannarino A, Nickell PV. Evaluating the impact of Fresspira on panic disorder patients’ health outcomes and healthcare cost within the Allegheny Health Network. Appl Psychophys Biof. 2020;45:175–181.

 

Jelovsek JE, Markland AD, Whitehead WE, et al. Controlling fecal incontinence in women by performing anal exercises with biofeedback or loperamide: A randomized clinical trial. Lancet Gastroenterol Hepatol. 2019;4(9):698-710.

 

Wegh CAM, Baaleman DF, Tabbers MM, Smidt H, Benninga MA. Nonpharmacologic treatment for children with functional constipation: A systematic review and meta-analysis. J Pediatr. 2022;240:136-149.e5.

 

Hite M, Curran T. Biofeedback for pelvic floor disorders. Clin Colon Rectal Surg. 2021;34(1):56-61.

 

Alneyadi M, Drissi N, Almeqbaali M, Ouhbi S. Biofeedback-based connected mental health interventions for anxiety: Systematic literature review. JMIR Mhealth Uhealth. 2021;9(4):e26038.

 

Rao SSC, Go JT, Valestin J, Schneider J. Home biofeedback for the treatment of dyssynergic defecation: Does it improve quality of life and is it cost-effective? Am J Gastroenterol. 2019;114(6):938-944.

 

Medicare Internet Only Manual (IOM), Pub. 100-03, National Coverage Determinations (NCD) Manual, Chapter 1, Part 1, Section 30.1. Effective: This is a longstanding national coverage determination. The effective date of this version has not been posted.

 

Wu X, Zheng X, Yi X, Lai P, Lan Y. Electromyographic biofeedback for stress urinary incontinence or pelvic floor dysfunction in women: A systematic review and meta-analysis. Adv Ther. 2021;38(8):4163-4177.

 

Hagen S, Elders A, Stratton S, et al. Effectiveness of pelvic floor muscle training with and without electromyographic biofeedback for urinary incontinence in women: Multicentre randomised controlled trial. BMJ. 2020;371:m3719.

 

Santucci NR, Chogle A, Leiby A, et al. Non-pharmacologic approach to pediatric constipation. Complement Ther Med. 2021;59:102711.

 

Ostacher MJ, Fischer E, Bowen ER, Lyu J, Robbins DJ, Suppes T. Investigation of a capnometry guided respiratory intervention in the treatment of posttraumatic stress disorder. Appl Psychophysiol Biofeedback. 2021;46(4):367-376.

 

 Minen MT, Corner S, Berk T, et al. Heartrate variability biofeedback for migraine using a smartphone application and sensor: A randomized controlled trial. Gen Hosp Psychiatry. 2021;69:41-49.